Back

Watch Compare

NATURAL HEALTH TRENDS CORP

Data quality: 100%

NHTC

Nasdaq Wholesale Trade Nondurable Goods Wholesale

$2.85

▲ $0.01 (0.35%)

Mkt Cap: 24.45 M

Price

$2.85

Mkt Cap

24.45 M

Day Range

$2.75 — $2.86

52-Week Range

$2.40 — $6.00

Volume

16,591

Open $2.86

50D / 200D Avg

$3.27

12.90% below

50D / 200D Avg

$3.85

26.03% below

Quick Summary

Key Takeaways

Revenue declined -9.77% annually over 5 years

Earnings declined -254.20% over the past year

Negative free cash flow of -6.07 M

Capital efficient — spends only 0.17% of revenue on capex

Growth

Revenue Growth (5Y)

-9.77%

Below sector avg (2.60%)

Revenue (1Y)-7.42%

Earnings (1Y)-254.20%

FCF Growth (3Y)N/A

Quality

Return on Equity

-3.21%

Above sector avg (-3.22%)

ROIC-4.95%

Net Margin-2.22%

Op. Margin-4.55%

Safety

Debt / Equity

N/A

Current Ratio2.57

Interest CoverageN/A

Valuation

PE (TTM)

-27.72

Below sector avg (-0.15)

P/B Ratio0.93

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Wholesale Trade sector median (91 peers)

Metric	Stock	Sector Median
P/E	-27.7	-0.2
P/B	0.9	1.0
ROE %	-3.2	-3.2
Net Margin %	-2.2	-2.7
Rev Growth 5Y %	-9.8	2.6
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-7.42%	Revenue Growth (3Y)	-4.84%
Earnings Growth (1Y)	-254.20%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	-9.77%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	39.78 M	Net Income (TTM)	-882,000.0
ROE	-3.21%	ROA	-2.02%
Gross Margin	73.54%	Operating Margin	-4.55%
Net Margin	-2.22%	Free Cash Flow (TTM)	-6.07 M
ROIC	-4.95%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	2.57
Interest Coverage	N/A	Asset Turnover	0.91
Working Capital	23.13 M	Tangible Book Value	26.15 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-27.72	Forward P/E	N/A
P/B Ratio	0.93	P/S Ratio	0.61
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-24.81%
Market Cap	24.45 M	Enterprise Value	10.11 M
Per Share
EPS (Diluted TTM)	-0.08	Revenue / Share	4.64
FCF / Share	-0.71	OCF / Share	-0.70
EPS CAGR (1Y)	-260.00%	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	0.17%	FCF Conversion	687.64%
SBC-Adj. FCF	-6.20 M	Growth Momentum	2.35

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	39.78 M	42.96 M	43.92 M	49.13 M	60.01 M
Net Income	-882,000.0	572,000.0	568,000.0	313,000.0	1.09 M
EPS (Diluted)	-0.08	0.05	0.05	0.03	0.09
Gross Profit	29.25 M	31.79 M	32.75 M	36.47 M	45.00 M
Operating Income	-1.81 M	-1.30 M	-1.67 M	-270,000.0	1.57 M
EBITDA	—	—	—	—	—
R&D Expenses	—	—	—	—	—
SG&A Expenses	14.76 M	15.51 M	16.01 M	16.00 M	17.85 M
D&A	109,000.0	131,000.0	164,000.0	204,000.0	299,000.0
Interest Expense	—	—	—	—	—
Income Tax	315,000.0	48,000.0	177,000.0	289,000.0	425,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	38.43 M	55.36 M	69.09 M	82.82 M	98.36 M
Total Liabilities	15.00 M	22.49 M	27.49 M	32.67 M	38.87 M
Shareholders' Equity	23.43 M	32.87 M	41.60 M	50.15 M	59.49 M
Total Debt	—	—	—	—	—
Cash & Equivalents	6.81 M	13.53 M	56.18 M	69.67 M	83.84 M
Current Assets	34.19 M	50.98 M	64.23 M	77.55 M	93.47 M
Current Liabilities	13.69 M	20.80 M	19.98 M	20.44 M	24.66 M